julie vose, md, tells us about results of the augment study in relapsed/refractory indolent nhl
Published 5 years ago • 22 plays • Length 0:37
Download video MP4
Download video MP3
Similar videos
-
0:49
julie vose, md, on if car-t therapies are showing impressive results in lymphoma
-
0:37
julie vose, md, discusses improvements made in the delivery of car-t therapies in lymphoma
-
58:08
winship grand rounds november 29, 2017: julie m. vose, md, mba
-
0:21
julie vose, md, discusses whether polatuzumab improves outcomes in dlbcl patients
-
0:44
julie vose, md, on management of common toxicities with car-t therapies
-
0:55
julie vose, md, on the ‘ultimate goal’ of lymphoma research
-
0:52
julie gralow, md, tells us about the sandpiper proof of concept trial presented at acso 2018
-
0:41
julie brahmer, md, talks about the potential impact of immunotherapy in 1st line nsclc
-
0:42
results establishing lenalidomide plus rituximab as superior treatment in non-hodgkin lymphoma
-
55:05
novel targeted therapy for low-grade lymphoid malignancies in older adults by dr. krem
-
0:44
julie gralow, md, regarding the reduction in cardiac events in the persephone study
-
0:37
julie gralow, md, comments on the practice-changing implications of the tailorx study
-
1:06
epcore nhl-1: two and a half year follow-up of epcoritamab in dlbcl
-
57:36
novel therapies in the management of patients with lymphoma
-
1:44
the molecular and microenvironmental basis of immunodysfunction in cll
-
5:45
maintenance therapy outcomes in follicular lymphoma
-
0:50
julie gralow, md, discusses the monarch 1 study
-
1:06
askunmc: lymphoma treatment
-
2:35
julie gralow, md, elaborates on the issue of resistance to endocrine therapies
Clip.africa.com - Privacy-policy